Efficacy of a Non-Hypercalcemic Vitamin-D2 Derived Anti-Cancer Agent (MT19c) and Inhibition of Fatty Acid Synthesis in an Ovarian Cancer Xenograft Model
Richard G. Moore(University of Rochester Medical Center), Ajay Singh(Thapar Institute of Engineering & Technology)
Cited by 20
Related Papers
Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
|Kidney International|2016|474
Silicon Oxycarbide Glasses
|Journal of Sol-Gel Science and Technology|1999|404
Tetrathiomolybdate inhibits mitochondrial complex IV and mediates degradation of hypoxia-inducible factor-1α in cancer cells
|Scientific Reports|2015|62
Liposome encapsulated vitamin A compounds exhibit greater stability and diminished toxicity
|Biophysical Chemistry|1998|59